Vote for your favorite mineral in #MinCup25! - Kosmochlor vs. Azurite
It's a battle of green vs blue as rare but vibrant chromium-bearing kosmochlor up against the deep blue copper alteration mineral azurite.
Log InRegister
Quick Links : The Mindat ManualThe Rock H. Currier Digital LibraryMindat Newsletter [Free Download]
Home PageAbout MindatThe Mindat ManualHistory of MindatCopyright StatusWho We AreContact UsAdvertise on Mindat
Donate to MindatCorporate SponsorshipSponsor a PageSponsored PagesMindat AdvertisersAdvertise on Mindat
Learning CenterWhat is a mineral?The most common minerals on earthInformation for EducatorsMindat ArticlesThe ElementsThe Rock H. Currier Digital LibraryGeologic Time
Minerals by PropertiesMinerals by ChemistryAdvanced Locality SearchRandom MineralRandom LocalitySearch by minIDLocalities Near MeSearch ArticlesSearch GlossaryMore Search Options
Search For:
Mineral Name:
Locality Name:
Keyword(s):
 
The Mindat ManualAdd a New PhotoRate PhotosLocality Edit ReportCoordinate Completion ReportAdd Glossary Item
Mining CompaniesStatisticsUsersMineral MuseumsClubs & OrganizationsMineral Shows & EventsThe Mindat DirectoryDevice SettingsThe Mineral Quiz
Photo SearchPhoto GalleriesSearch by ColorNew Photos TodayNew Photos YesterdayMembers' Photo GalleriesPast Photo of the Day GalleryPhotography

Zhao, Xiangde, Ning, Lei, Xie, Ziang, Jie, Zhiwei, Li, Xiang, Wan, Xinyu, Sun, Xuewu, Huang, Bao, Tang, Pan, Shen, Shuying, Qin, An, Ma, Yan, Song, Lu, Fan, Shunwu, Wan, Shuanglin (2019) The Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen‐Dependent Bone Loss in Mice. Journal of Bone and Mineral Research, 34 (5). 911-922 doi:10.1002/jbmr.3655

Advanced
   -   Only viewable:
Reference TypeJournal (article/letter/editorial)
TitleThe Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen‐Dependent Bone Loss in Mice
JournalJournal of Bone and Mineral Research
AuthorsZhao, XiangdeAuthor
Ning, LeiAuthor
Xie, ZiangAuthor
Jie, ZhiweiAuthor
Li, XiangAuthor
Wan, XinyuAuthor
Sun, XuewuAuthor
Huang, BaoAuthor
Tang, PanAuthor
Shen, ShuyingAuthor
Qin, AnAuthor
Ma, YanAuthor
Song, LuAuthor
Fan, ShunwuAuthor
Wan, ShuanglinAuthor
Year2019 (May)Volume34
Issue5
PublisherWiley
DOIdoi:10.1002/jbmr.3655Search in ResearchGate
Generate Citation Formats
Mindat Ref. ID7730173Long-form Identifiermindat:1:5:7730173:8
GUID0
Full ReferenceZhao, Xiangde, Ning, Lei, Xie, Ziang, Jie, Zhiwei, Li, Xiang, Wan, Xinyu, Sun, Xuewu, Huang, Bao, Tang, Pan, Shen, Shuying, Qin, An, Ma, Yan, Song, Lu, Fan, Shunwu, Wan, Shuanglin (2019) The Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen‐Dependent Bone Loss in Mice. Journal of Bone and Mineral Research, 34 (5). 911-922 doi:10.1002/jbmr.3655
Plain TextZhao, Xiangde, Ning, Lei, Xie, Ziang, Jie, Zhiwei, Li, Xiang, Wan, Xinyu, Sun, Xuewu, Huang, Bao, Tang, Pan, Shen, Shuying, Qin, An, Ma, Yan, Song, Lu, Fan, Shunwu, Wan, Shuanglin (2019) The Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen‐Dependent Bone Loss in Mice. Journal of Bone and Mineral Research, 34 (5). 911-922 doi:10.1002/jbmr.3655
In(2019, May) Journal of Bone and Mineral Research Vol. 34 (5) Wiley

See Also

These are possibly similar items as determined by title/reference text matching only.

Zhao, Xiangde, Ning, Lei, Xie, Ziang, Jie, Zhiwei, Li, Xiang, Wan, Xinyu, Sun, Xuewu, Huang, Bao, Tang, Pan, Shen, Shuying, Qin, An, Ma, Yan, Song, Lu, Fan, Shunwu, Wan, Shuanglin (2020) The Novel p38 Inhibitor, Pamapimod, Inhibits Osteoclastogenesis and Counteracts Estrogen‐Dependent Bone Loss in Mice. Journal of Bone and Mineral Research, 35 (8) 1618-1619 doi:10.1002/jbmr.4095
Wang, Shiyu, Ma, Qingliang, Xie, Ziang, Shen, Yang, Zheng, Bingjie, Jiang, Chao, Yuan, Putao, An, Qin, Fan, Shunwu, Jie, Zhiwei (2021) An Antioxidant Sesquiterpene Inhibits Osteoclastogenesis Via Blocking IPMK/TRAF6 and Counteracts OVX‐ Induced Osteoporosis in Mice. Journal of Bone and Mineral Research, 36 (9) 1850-1865 doi:10.1002/jbmr.4328
Ma, Qingliang, Wang, Shiyu, Xie, Ziang, Shen, Yang, Zheng, Bingjie, Jiang, Chao, Yuan, Putao, Yu, Congcong, Li, Liangping, Zhao, Xiangde, Chen, Junxin, Qin, An, Fan, Shunwu, Jie, Zhiwei (2022) The SFRP1 Inhibitor WAY ‐316606 Attenuates Osteoclastogenesis Through Dual Modulation of Canonical Wnt Signaling. Journal of Bone and Mineral Research, 37 (1) 152-166 doi:10.1002/jbmr.4435
Xie, Zi'ang, Yu, Hejun, Sun, Xuewu, Tang, Pan, Jie, Zhiwei, Chen, Shuai, Wang, Jiying, Qin, An, Fan, Shunwu (2018) A Novel Diterpenoid Suppresses Osteoclastogenesis and Promotes Osteogenesis by Inhibiting Ifrd1-Mediated and IκBα-Mediated p65 Nuclear Translocation. Journal of Bone and Mineral Research, 33 (4). 667-678 doi:10.1002/jbmr.3334
Xie, Ziang, Hou, Lei, Shen, Shuying, Wu, Yizheng, Wang, Jian, Jie, Zhiwei, Zhao, Xiangde, Li, Xiang, Zhang, Xuyang, Chen, Junxin, Xu, Wenbin, Ning, Lei, Ma, Qingliang, Wang, Shiyu, Wang, Haoming, Yuan, Putao, Fang, Xiangqian, Qin, An, Fan, Shunwu (2022) Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation. Nature Communications, 13 (1) doi:10.1038/s41467-021-27629-2
Wu, Yizheng, Shen, Shuying, Chen, Jiaxin, Ni, Weiyu, Wang, Qinxin, Zhou, Hongyi, Chen, Junxin, Zhang, Haitao, Mei, Zixuan, Sun, Xuewu, Shen, Panyang, Jie, Zhiwei, Xu, Wenbin, Hong, Zhenghua, Ma, Yan, Wang, Kefan, Wan, Shuanglin, Wu, Hongfei, Xie, Ziang, Qin, An, Fan, Shunwu (2023) Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis. Science Advances, 9 (6) doi:10.1126/sciadv.ade5584
Ning, Lei, Wan, Shuanglin, Fan, Shunwu (2020) Some Questions About the Article “The Efficacy and Safety of Vertebral Augmentation: A Second ASBMR Task Force Report”. Journal of Bone and Mineral Research, 35 (1). 211 doi:10.1002/jbmr.3907
Lu, Di, Li, Jianshuang, Liu, Huadie, Foxa, Gabrielle E, Weaver, Kevin, Li, Jie, Williams, Bart O, Yang, Tao (2018) LRP1 Suppresses Bone Resorption in Mice by Inhibiting the RANKL-Stimulated NF-κB and p38 Pathways During Osteoclastogenesis. Journal of Bone and Mineral Research, 33 (10). 1773-1784 doi:10.1002/jbmr.3469
Dong, Hui, Liu, Ronghan, Zou, Ke, Jin, Zhengxin, Kang, Jianning, Zhang, Ying, Zhang, Xiaodi, Sun, Zhengfang, Yu, Guilian, Huang, Nana, Bretches, Morgan, Yang, Shang‐You, Ning, Bin (2023) Higenamine Promotes Osteogenesis Via IQGAP1 / SMAD4 Signaling Pathway and Prevents Age‐ and Estrogen‐Dependent Bone Loss in Mice. Journal of Bone and Mineral Research, 38 (5) 775-791 doi:10.1002/jbmr.4800
Wang, Bo, Pan, Jin‐Xiu, Yu, Huali, Xiong, Lei, Zhao, Kai, Xiong, Shan, Guo, Jun‐Peng, Lin, Sen, Sun, Dong, Zhao, Lu, Guo, Haohan, Mei, Lin, Xiong, Wen‐Cheng (2019) Lack of Myosin X Enhances Osteoclastogenesis and Increases Cell Surface Unc5b in Osteoclast‐Lineage Cells. Journal of Bone and Mineral Research, 34 (5). 939-954 doi:10.1002/jbmr.3667
Zhou, Yan‐Man, Yang, Yu‐Ying, Jing, Yi‐Xuan, Yuan, Tian‐Jiao, Sun, Li‐Hao, Tao, Bei, Liu, Jian‐Min, Zhao, Hong‐Yan (2020) BMP9 Reduces Bone Loss in Ovariectomized Mice by Dual Regulation of Bone Remodeling. Journal of Bone and Mineral Research, 35 (5) 978-993 doi:10.1002/jbmr.3957
 
and/or  
Mindat.org is an outreach project of the Hudson Institute of Mineralogy, a 501(c)(3) not-for-profit organization.
Copyright © mindat.org and the Hudson Institute of Mineralogy 1993-2025, except where stated. Most political location boundaries are © OpenStreetMap contributors. Mindat.org relies on the contributions of thousands of members and supporters. Founded in 2000 by Jolyon Ralph.
To cite: Ralph, J., Von Bargen, D., Martynov, P., Zhang, J., Que, X., Prabhu, A., Morrison, S. M., Li, W., Chen, W., & Ma, X. (2025). Mindat.org: The open access mineralogy database to accelerate data-intensive geoscience research. American Mineralogist, 110(6), 833–844. doi:10.2138/am-2024-9486.
Privacy Policy - Terms & Conditions - Contact Us / DMCA issues - Report a bug/vulnerability Current server date and time: September 9, 2025 13:26:53
Go to top of page